ICU Medical, Inc. to Present at 34th Annual J.P. Morgan Healthcare Conference

SAN CLEMENTE, Calif., Jan. 04, 2016 (GLOBE NEWSWIRE) — ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy, oncology and critical care applications, today announced that CEO Vivek Jain will be presenting at the 34th Annual J.P. Morgan Healthcare Conference to be held on January 11-14, 2016, at the Westin St. Francis Hotel in San Francisco, California.

ICU Medical’s presentation will take place on Wednesday, January 13th at 4:00 PM Pacific Time.

The presentation will be webcast live and can be accessed by going to the Company’s website at, clicking on the Investors tab and clicking on the Event Calendar tab. The webcast will also be available by replay.

About ICU Medical, Inc.

ICU Medical, Inc. (Nasdaq:ICUI) develops, manufactures and sells innovative medical technologies used in infusion therapy, oncology, and critical care applications. ICU Medical’s products improve patient outcomes by helping prevent bloodstream infections and protect healthcare workers from exposure to infectious diseases or hazardous drugs. The Company’s complete product line includes custom IV systems, closed delivery systems for hazardous drugs, needlefree IV connectors, closed blood sampling systems, and hemodynamic monitoring systems. ICU Medical is headquartered in San Clemente, California. For more information, visit the Company’s website at


ICU Medical, Inc.
Scott Lamb, Chief Financial Officer
(949) 366-2183
ICR, Inc.
John Mills, Partner
(646) 277-1254